These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 39152131)

  • 1. Intradermal vaccination with a phytoglycogen nanoparticle and STING agonist induces cytotoxic T lymphocyte-mediated antitumor immunity.
    Hernandez-Franco JF; Jan IM; Elzey BD; HogenEsch H
    NPJ Vaccines; 2024 Aug; 9(1):149. PubMed ID: 39152131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer.
    Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H
    Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells.
    Verbeke R; Lentacker I; Breckpot K; Janssens J; Van Calenbergh S; De Smedt SC; Dewitte H
    ACS Nano; 2019 Feb; 13(2):1655-1669. PubMed ID: 30742405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both CD4+ and CD8+ T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors.
    Mizukami S; Kajiwara C; Ishikawa H; Katayama I; Yui K; Udono H
    Cancer Sci; 2008 May; 99(5):1008-15. PubMed ID: 18341654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4
    Luo J; Pang S; Hui Z; Zhao H; Xu S; Yu W; Yang L; Sun Q; Hao X; Wei F; Wang J; Ren X
    Theranostics; 2023; 13(14):4836-4857. PubMed ID: 37771774
    [No Abstract]   [Full Text] [Related]  

  • 6. Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization.
    Hernandez-Franco JF; Yadagiri G; Patil V; Bugybayeva D; Dolatyabi S; Dumkliang E; Singh M; Suresh R; Akter F; Schrock J; Renukaradhya GJ; HogenEsch H
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly synthesized AIFM1 determines the hypersensitivity of T lymphocytes to STING activation-induced cell apoptosis.
    Ji W; Zhang L; Ma C; Xu X; Li S; Xia H; Zhou W; Liu X
    Cell Rep; 2023 Apr; 42(4):112327. PubMed ID: 37000625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs.
    Patil V; Hernandez-Franco JF; Yadagiri G; Bugybayeva D; Dolatyabi S; Feliciano-Ruiz N; Schrock J; Hanson J; Ngunjiri J; HogenEsch H; Renukaradhya GJ
    J Nanobiotechnology; 2022 Nov; 20(1):477. PubMed ID: 36369044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant.
    Hernandez-Franco JF; Xie S; Thimmapuram J; Ragland D; HogenEsch H
    Front Immunol; 2022; 13():990900. PubMed ID: 36131928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives.
    Patil V; Hernandez-Franco JF; HogenEsch H; Renukaradhya GJ
    Front Immunol; 2022; 13():858321. PubMed ID: 36119085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.
    Garland KM; Sheehy TL; Wilson JT
    Chem Rev; 2022 Mar; 122(6):5977-6039. PubMed ID: 35107989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.
    Meric-Bernstam F; Sweis RF; Hodi FS; Messersmith WA; Andtbacka RHI; Ingham M; Lewis N; Chen X; Pelletier M; Chen X; Wu J; McWhirter SM; Müller T; Nair N; Luke JJ
    Clin Cancer Res; 2022 Feb; 28(4):677-688. PubMed ID: 34716197
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.